GlassScriptPhysician profile
Aaron S Iddings
NPI 1871988345
$712.01
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $43.25 · 2024: $451 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.99 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $115.05 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $81.20 | 2024-2025 | Opdivo, Krazati |
| Merck Sharp & Dohme LLC | $56.74 | 2024 | Keytruda |
| Glaxosmithkline, LLC. | $56.42 | 2024 | Jemperli, Zejula |
| Novartis Pharmaceuticals Corporation | $54.17 | 2024-2025 | |
| Eisai INC. | $51.21 | 2023-2025 | |
| Astellas Pharma US INC | $46.40 | 2024-2025 | Padcev |
| Janssen Biotech, INC. | $42.27 | 2024 | Rybrevant |
| Regeneron Healthcare Solutions, INC. | $40.95 | 2024-2025 | Libtayo |
| Mirati Therapeutics, INC. | $30.35 | 2024 | Krazati |
| Puma Biotechnology, INC. | $29.87 | 2024 | |
| Lilly USA, LLC | $24.50 | 2024 | Jaypirca, Verzenio |
| Coherus Oncology, INC. | $24.38 | 2025 | Loqtorzi |
| Caris Mpi, INC. | $23.75 | 2025 | Mi Cancer Seek |
| Gilead Sciences, INC. | $18.31 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.44 | 2024 | Calquence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Iddings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.